WKN: | A0SM6H |
ISIN: | DE000A0SM6H1 |
Region: | Deutschland |
Sektor: | Immobilien |
EQS-News: Galimedix, Inc. / Key word(s): Study results Progress in clinical development for Alzheimer´s and other indications: Galimedix Therapeutics successfully completes Phase 1 study with oral small molecule, GAL-101, an amyloid beta... ...weiterlesen